Sagimet Biosciences Inc.
USD7.70
-0.09 (-1.19%)
CEO
David Happel
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.70
Prev. Close
$7.79
Day Low
$7.60
Day High
$7.78
52W Low
$4.50
52W High
$11.41
Market Cap
$0.25B
Volume
0.10M
| -3.1 |
| 31 Dec 2023 | FY | 100.0% | -1393.8% | -30.6% | -28.8% | 0.00 | 17.09 | -3.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 16.3% | -92.3% | -0.00 | 6.21 | -11.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 15.4% | -41.4% | -0.00 | 24.04 | -14.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 8.4% | -16.5% | -0.00 | 35.99 | -31.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 11.4% | -127.8% | -0.00 | 5.21 | -24.8 |
| -5.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -10.8% | -10.1% | 0.00 | 13.04 | -4.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.0% | -7.6% | 0.00 | 17.55 | -5.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -13.1% | -12.4% | 0.00 | 20.34 | -1.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -10.4% | -10.1% | 0.00 | 34.30 | -2.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -8.6% | -8.4% | 0.00 | 38.41 | -1.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -4.4% | -4.3% | 0.00 | 29.11 | -3.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -3.5% | -3.4% | 0.00 | 43.12 | -5.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -9.0% | -8.4% | 0.00 | 17.09 | -3.0 |